Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment

Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the ch...

Full description

Bibliographic Details
Main Authors: Huseyin Avni Solgun, Seyma Acikgoz, Duygu Ozkorucu Yildirgan, Ozlem Terzi, Ali Aycicek
Format: Article
Language:English
Published: Galenos Yayinevi 2023-06-01
Series:Haseki Tıp Bülteni
Subjects:
Online Access: http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803
_version_ 1827908097828454400
author Huseyin Avni Solgun
Seyma Acikgoz
Duygu Ozkorucu Yildirgan
Ozlem Terzi
Ali Aycicek
author_facet Huseyin Avni Solgun
Seyma Acikgoz
Duygu Ozkorucu Yildirgan
Ozlem Terzi
Ali Aycicek
author_sort Huseyin Avni Solgun
collection DOAJ
description Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the chronic diseases caused by the Mycobacterium tuberculosis bacillus, which has high morbidity and mortality and occurs most frequently in the lung. In this case report, we present a patient with a previous diagnosis of BL who developed pleural effusion while under rituximab-ifosfamide carboplatin etoposide treatment, and TB polymerase chain reaction (PCR) was revealed to be positive in the TB PCR screening test of the pleural fluid. To our knowledge, there is no previous study of the coexistence of BL and TB pleurisy in the literature. When pleural effusion develops in patients with BL under chemotherapy treatment, it should be kept in mind that TB may be present, and anti-TB treatment should be started as soon as the diagnosis is made. There is limited information in the literature about the frequency of tuberculous pleurisy in patients with BL.
first_indexed 2024-03-13T01:17:14Z
format Article
id doaj.art-282281d3328848f9ac548eb14f161a47
institution Directory Open Access Journal
issn 1302-0072
2147-2688
language English
last_indexed 2024-03-13T01:17:14Z
publishDate 2023-06-01
publisher Galenos Yayinevi
record_format Article
series Haseki Tıp Bülteni
spelling doaj.art-282281d3328848f9ac548eb14f161a472023-07-05T08:52:23ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882023-06-0161321021310.4274/haseki.galenos.2023.906213049054Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab TreatmentHuseyin Avni Solgun0Seyma Acikgoz1Duygu Ozkorucu Yildirgan2Ozlem Terzi3Ali Aycicek4 University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Pediatrics, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, Istanbul, Turkey Non-Hodgkin’s lymphoma (NHL) accounts for 60% of childhood lymphomas and is the fourth most common childhood malignancy. Burkitt’s lymphoma (BL) accounts for 40% of NHLs. Burkitt’s lymphoma is mostly of abdominal origin and has the highest cell count doubling rate. Tuberculosis (TB) is one of the chronic diseases caused by the Mycobacterium tuberculosis bacillus, which has high morbidity and mortality and occurs most frequently in the lung. In this case report, we present a patient with a previous diagnosis of BL who developed pleural effusion while under rituximab-ifosfamide carboplatin etoposide treatment, and TB polymerase chain reaction (PCR) was revealed to be positive in the TB PCR screening test of the pleural fluid. To our knowledge, there is no previous study of the coexistence of BL and TB pleurisy in the literature. When pleural effusion develops in patients with BL under chemotherapy treatment, it should be kept in mind that TB may be present, and anti-TB treatment should be started as soon as the diagnosis is made. There is limited information in the literature about the frequency of tuberculous pleurisy in patients with BL. http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803 burkitt’s lymphomatuberculosispleural effusiontuberculous pleurisyrituksimab
spellingShingle Huseyin Avni Solgun
Seyma Acikgoz
Duygu Ozkorucu Yildirgan
Ozlem Terzi
Ali Aycicek
Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
Haseki Tıp Bülteni
burkitt’s lymphoma
tuberculosis
pleural effusion
tuberculous pleurisy
rituksimab
title Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
title_full Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
title_fullStr Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
title_full_unstemmed Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
title_short Tuberculosis Pleurisy in a Case of Burkitt Lymphoma Secondary to Rituksimab Treatment
title_sort tuberculosis pleurisy in a case of burkitt lymphoma secondary to rituksimab treatment
topic burkitt’s lymphoma
tuberculosis
pleural effusion
tuberculous pleurisy
rituksimab
url http://www.hasekidergisi.com/archives/archive-detail/article-preview/tuberculosis-pleurisy-in-a-case-of-burkitt-lymphom/60803
work_keys_str_mv AT huseyinavnisolgun tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment
AT seymaacikgoz tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment
AT duyguozkorucuyildirgan tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment
AT ozlemterzi tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment
AT aliaycicek tuberculosispleurisyinacaseofburkittlymphomasecondarytorituksimabtreatment